Showing results (81-90 of 400) with videos related to

Sort By:
Pageof 40
BJU International|August 30, 2012
A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancerAnirban P Mitra, Eila C Skinner, Gus Miranda, et al.
Urology|July 19, 2023
Metastatic Testicular Cancer Patterns and Predictors: A Contemporary Population-based SEER AnalysisYash B Shah, Hanan Goldberg, Brian Hu, et al.
Urologic Oncology|November 15, 2011
The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observationSiamak Daneshmand, Andrew J Stephenson, Joel Sheinfeld, et al.
Expert Review of Anticancer Therapy|December 21, 2004
The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancerMarcus L Quek, Kristin M Sanderson, Siamak Daneshmand, et al.
Urology|January 15, 2014
Mesenteric lymphadenopathy in testicular germ cell tumorHooman Djaladat, Kamran Movassaghi, Hamed Ahmadi, et al.
Oncology (Williston Park, N.Y.)|December 13, 2006
Management of difficult germ-cell tumorsChristie J Moore, Siamak Daneshmand, G Varuni Kondagunta, et al.
The Journal of Urology|May 17, 2011
The debate over percutaneous nephrolithotomy positioning: a comprehensive reviewBrian Duty, Zhamshid Okhunov, Arthur Smith, et al.
The Journal of Urology|December 20, 2011
Medical malpractice in endourology: analysis of closed cases from the State of New YorkBrian Duty, Zhamshid Okhunov, Zeph Okeke, et al.
Urology|December 2, 2017
Vena Cavoscopy in the Assessment of Intraluminal Vena Caval Tumor InvolvementJeffrey Loh-Doyle, Sumeet Bhanvadia, Mukul B Patil, et al.
Urologic Oncology|April 21, 2012
Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen eraRyan P Dorin, Gary Lieskovsky, Adrian S Fairey, et al.
Pageof 40